Marfan Syndrome is a relatively rare genetic disorder that affects the connective tissues in the body. It is estimated to occur in approximately 1 in every 5,000 to 10,000 individuals worldwide. Although it can affect people of all races and ethnicities, it is more commonly found in certain populations, such as those of European descent.
The prevalence of Marfan Syndrome can vary across different regions and populations. Studies have shown that it affects males and females equally. The condition is typically inherited in an autosomal dominant manner, meaning that an affected individual has a 50% chance of passing the syndrome on to each of their children.
Marfan Syndrome can affect multiple body systems, including the skeletal, cardiovascular, and ocular systems. It is characterized by a range of symptoms, including tall stature, long limbs, joint hypermobility, scoliosis, heart abnormalities, and lens dislocation.
Early diagnosis and management are crucial in improving the quality of life for individuals with Marfan Syndrome. Regular medical follow-ups, monitoring of cardiovascular health, and appropriate interventions can help prevent complications and ensure optimal outcomes for affected individuals.